Bristol-Myers Squibb Company
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Bristol-Myers Squibb Company (BMY) Business News
Track Bristol-Myers Squibb Company in real time with a live news feed covering Bristol-Myers Squibb Company stock news, official press releases, company announcements, and an archive of historical Bristol-Myers Squibb Company news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note
Bristol Myers Squibb (BMY) is a Top-Ranked Momentum Stock: Should You Buy?
Retirees Are Quickly Moving Into These Dividend Funds
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Cary Street Partners Financial LLC Increases Stake in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb (BMY) is a Top-Ranked Momentum Stock: Should You Buy?
Retirees Are Quickly Moving Into These Dividend Funds
Cary Street Partners Financial LLC Increases Stake in Bristol Myers Squibb Company $BMY
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
5 Very Safe High-Yield Dividend Stocks Boomers Can Hold Forever
NYSE Content Update: Two MSCI Indexes to Begin Trading on NYSE Arca Options
First Financial Bankshares Inc Takes Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia
Citigroup Inc. Lowers Stock Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note
6:45 PM | Friday | Feb 27, 2026
In the latest trading session, Bristol Myers Squibb (BMY) closed at $62.37, marking a +2.08% move from the previous day.
Read full article
Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note
Zacks Investment ResearchIn the latest trading session, Bristol Myers Squibb (BMY) closed at $62.37, marking a +2.08% move from the previous day.
Read full article
Bristol Myers Squibb (BMY) is a Top-Ranked Momentum Stock: Should You Buy?
Zacks Investment ResearchThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read full article
Retirees Are Quickly Moving Into These Dividend Funds
24/7 Wall StreetShifting from higher-risk assets to consistent income sources is a natural progression for retirees.
Read full article
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Business WireREDMOND, Wash. & PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Patients--SystImmune and BMS Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously-Treated Unresectable.
Read full article
Cary Street Partners Financial LLC Increases Stake in Bristol Myers Squibb Company $BMY
Defense WorldCary Street Partners Financial LLC grew its stake in Bristol Myers Squibb Company (NYSE: BMY) by 11.6% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 106,445 shares of the biopharmaceutical company's stock after purchasing an additional 11,086 shares
Read full article
Bristol Myers Squibb (BMY) is a Top-Ranked Momentum Stock: Should You Buy?
Zacks Investment ResearchThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read full article
Retirees Are Quickly Moving Into These Dividend Funds
24/7 Wall StreetShifting from higher-risk assets to consistent income sources is a natural progression for retirees.
Read full article
Cary Street Partners Financial LLC Increases Stake in Bristol Myers Squibb Company $BMY
Defense WorldCary Street Partners Financial LLC grew its stake in Bristol Myers Squibb Company (NYSE: BMY) by 11.6% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 106,445 shares of the biopharmaceutical company's stock after purchasing an additional 11,086 shares
Read full article
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
Zacks Investment ResearchWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read full article
5 Very Safe High-Yield Dividend Stocks Boomers Can Hold Forever
24/7 Wall StreetWhile many Baby Boomers have enjoyed a long bull market over the past 35 years, there is a point when income becomes more critical than stock appreciation.
Read full article
NYSE Content Update: Two MSCI Indexes to Begin Trading on NYSE Arca Options
PRNewsWireNYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Feb. 25, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor.
Read full article
First Financial Bankshares Inc Takes Position in Bristol Myers Squibb Company $BMY
Defense WorldFirst Financial Bankshares Inc acquired a new position in shares of Bristol Myers Squibb Company (NYSE: BMY) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 9,522 shares of the biopharmaceutical company's stock, valued at approximately $429,000. A number of other large investors also
Read full article
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Zacks Investment ResearchRecently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
Read full article
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia
Business WirePRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia.
Read full article
Citigroup Inc. Lowers Stock Position in Bristol Myers Squibb Company $BMY
Defense WorldCitigroup Inc. reduced its position in Bristol Myers Squibb Company (NYSE: BMY) by 30.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,707,893 shares of the biopharmaceutical company's stock after selling 1,197,195 shares during the quarter. Citigroup Inc.
owned about 0.13% of